edgepedia

Medical and health researchers

8,517 articles

Thomas Force

Thomas Force, also known as Thomas Lee Force, was an American cardiologist whose 2006 finding that the cancer drug imatinib causes heart failure launched cardio-oncology.

Thomas Francis, Jr.

Thomas Francis, Jr. (1900–1969) was an American physician, virologist, and epidemiologist who first identified influenza B, coined original antigenic sin, and directed the 1954 Salk polio vaccine field trial.

Thomas G. Brott

Thomas G. Brott is an American neurologist and stroke researcher who designed the NIH Stroke Scale, pioneered tPA for stroke, and led the CREST trials.

Thomas G. Pickering

Thomas G. Pickering was a British-born physician-scientist, professor at Columbia University, who coined white-coat and masked hypertension and made out-of-office blood-pressure measurement part of routine cardiovascular medicine.

Thomas Gasser

Thomas Gasser is a neurologist who directs neurodegenerative disease research at the Hertie Institute in Tübingen and shared the 2024 Breakthrough Prize for identifying Parkinson's risk genes LRRK2 and GBA1.

Thomas H. Gallagher

Thomas H. Gallagher is an American general internist and patient-safety researcher at the University of Washington, known for research on disclosing medical errors and Communication-and-Resolution Programs.

Thomas H. Hostetter

Thomas H. Hostetter is an American nephrologist at the University of North Carolina, known for his 1982 review linking dietary protein to kidney disease progression.

Thomas H. Marwick

Thomas H. Marwick is an Australian cardiologist known for stress echocardiography and myocardial strain imaging, and director of the Baker Institute from 2016 to 2024.

Thomas H. Milhorat

Thomas H. Milhorat (1936–2025) was an American neurosurgeon who overturned the choroid plexus model of cerebrospinal fluid production and founded the Chiari Institute in 2001.

Thomas Helleday

Thomas Helleday is a Swedish chemical biologist and professor at Karolinska Institutet whose 2005 discovery that PARP inhibitors kill BRCA2-deficient tumors led to approved cancer drugs.

Thomas Hudson (geneticist)

Thomas J. Hudson is a Canadian genome scientist known for the first physical maps of the human genome, the HapMap Project, and founding the Ontario Institute for Cancer Research.

Thomas J. Braciale

Thomas J. Braciale (1946–2023) was an American immunologist and physician-scientist, founding director of the Beirne B. Carter Center for Immunology Research at the University of Virginia.

Thomas J. Coates

Thomas J. Coates is an American HIV/AIDS prevention researcher at UCLA who spent 21 years at UCSF, co-founded its Center for AIDS Prevention Studies, and led landmark trials of HIV voluntary counseling and testing in Africa.

Thomas J. Flotte

Thomas J. Flotte is an American dermatopathologist and researcher, a professor at Mayo Clinic in Rochester, Minnesota, who treats and studies melanoma and cutaneous T-cell lymphoma.

Thomas J. Kipps

Thomas J. Kipps (Thomas James Kipps) is an American hematologist-oncologist at UC San Diego whose work on chronic lymphocytic leukemia established ZAP-70 as a prognostic marker and advanced ibrutinib and ROR1-targeted therapy.

Thomas J. Lynch

Thomas J. Lynch is an American medical oncologist, president of Fred Hutchinson Cancer Center since 2020, known for the 2004 EGFR mutation discovery in lung cancer.

Thomas J. Marrie

Thomas J. Marrie, also published as T. J. Marrie, is a retired Canadian infectious-diseases physician known for pneumonia and Q fever research and two medical deanships.

Thomas J. Merimee

Thomas J. Merimee is an endocrinologist who studied the growth hormone–IGF axis, showing growth hormone's role in diabetic vascular disease through work on dwarfs and African Pygmies.

Thomas J. Montine

Thomas J. Montine is an American neuropathologist and chair of Pathology at Stanford University, a National Academy of Medicine member known for the 2018 biomarker-based definition of Alzheimer's disease.

Thomas J. Ryan

Thomas J. Ryan (1928–2020) was an American cardiologist at Boston University who led the Coronary Artery Surgery Study and served as American Heart Association president.

Thomas J. Smith

Thomas J. Smith is an American medical oncologist and palliative care physician, professor at Johns Hopkins since 2011, known for cancer cost research and ASCO's first palliative care guidelines.

Thomas J. Walsh

Thomas J. Walsh is an American physician-scientist in infectious diseases and medical mycology whose randomized trials in the New England Journal of Medicine reshaped antifungal therapy in cancer patients.

Thomas J. Wang

Thomas J. Wang is an American cardiologist and cardiovascular researcher who became dean of the University of Michigan Medical School in 2025, known for Framingham biomarker research.

Thomas Kissel

Thomas Kissel is a pharmaceutical scientist and professor at Philipps-Universität Marburg known for drug delivery and non-viral gene transfer research, including polyethylenimine carriers for DNA and siRNA delivery.

Thomas Klockgether

Thomas Klockgether, born 1956 in Cologne, is a German neurologist known for spinocerebellar ataxia research; he was Chair of Neurology at the University of Bonn from 1998 to 2024.

Thomas L. Benjamin

Thomas L. Benjamin is a virologist and emeritus professor at Harvard Medical School whose work on mouse polyomavirus helped establish roles of tyrosine kinases and PI3K in cancer.

Thomas L. Perry

Thomas L. Perry is a physician-biochemist who became a professor of pharmacology at the University of British Columbia in 1962, known for research on Huntington's chorea, Parkinson's disease, and inherited metabolic disorders of children.

Thomas L. Schwenk

Thomas L. Schwenk is an American family medicine physician and researcher on physician depression and well-being who served as Dean of the University of Nevada, Reno School of Medicine from 2011 to 2021.

Thomas Langer

Thomas Langer is a German biochemist who studies mitochondrial proteases and quality control; he directs the Department of Mitochondrial Proteostasis at the Max Planck Institute for Biology of Ageing in Cologne.

Thomas Lehner

Thomas Lehner is a British dental immunologist and Emeritus Professor at King's College London who established the world's first oral immunology department at Guy's Hospital in 1970.